What is the Projected CAGR value of the Immunotherapy Drugs Market?
Immunotherapy Drugs Market is expected to grow at a CAGR of 10.1% during the forecasting period 2023-2030.
Which region controlled the global market during 2023-2030?
North America region Controls the Immunotherapy Drugs Market during 2023-2030.
What are the factors driving the growth of the global immunotherapy drugs market?
Lifestyle diseases such as obesity, diabetes, and heart disease are becoming increasingly prevalent. These diseases can be treated with immunotherapy drugs. This is driving the growth of the immunotherapy drugs market.
Who are the key players in Immunotherapy Drugs Market?
Major players are F. Hoffmann-La Roche AG, GlaxoSmithKline plc. AbbVie, Inc., Amgen, Inc., Merck & Co., Inc., Alligator Bioscience, UbiVac, Bristol-Myers Squibb, Novartis International AG, and AstraZeneca plc, Daiichi Sankyo Company.